Frunexian is a selective and potent inhibitor of coagulation factor XI/activated factor XI (FXIa), exhibiting antithrombotic activity without bleeding tendency in a rat mesenteric artery puncture model; it can be used in extracorporeal membrane oxygenation (ECMO) research.